Oral ceftibuten switch therapy for acute pyelonephritis in children

Journal of the Medical Association of Thailand

Volumn 84, Issue SUPPL. 1, 2001, Pages

  Vilaichone, Aimon ^a   Watana, Dhevy ^a   Chaiwatanarat, Tawatchai ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Acute Pyelonephritis; Ceftibuten; Children; Switch Therapy; UTI

Indexed keywords

AMOXICILLIN; CEFTIBUTEN; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; SUCCIMER TC 99M;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; INFANT; KIDNEY SCAR; KIDNEY SCINTISCANNING; MALE; PYELONEPHRITIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; URINE CULTURE;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADOLESCENT; CEFTRIAXONE; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; INJECTIONS, INTRAVENOUS; MALE; PROSPECTIVE STUDIES; PYELONEPHRITIS; REFERENCE VALUES; TREATMENT OUTCOME;

EID: 0034815318     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Rosenfeld DL, Fleischer M, Yudd A, Makowshy T. Current recommmendations for children with urinary tract infections. Clin Ped 1995; 34: 261-4.
2. Hellerstein S. Urinary tract infections: old and new concepts. Pediatr Clin North Am 1995; 42: 1433-57.
3. th ed. Philadelphia: WB Saunders, 2000; 1621-5.
4. Hamilton MJ. Cefixime for switch therapy. Chemotherapy 1998; 44 (Suppl 1): 24-7.
5. Szekely E, Ludwig E. Efffectiveness of ceftibuten in the sequential therapy of respiratory and urinary tract infection. Orv Hetil 1999; 140: 1681-5.
6. Begue P. Antibiotic treatment of acute pyelonephritis in the child. Arch Pediatr 1998; 5 (Suppl 3): 296S-301S.
7. Barr WH, Arfrime M, Lin CC, Batra V. Pharmacokinetics of ceftibuten in children. Pediatr Infect Dis J 1995; 14: S93-01.
8. Banfi A, Garbriele G, Hill-Juarez JM, Kaufman A, Moens E. Multinational comparative trial of ceftibuten and trimethoprim-sulfamethoxazole in the treatment of children with complicated or recurrent urinary tract infections. Pediatr Infect Dis J 1993; 12: S84-91.
9. Washida H, Sakagami H, Awata S, Kan K, Kawai N, Inuzuka K. Morphological response of urinary bacteria to ceftibuten. Jpn J Antibiot 1996; 49: 273-8.
10. Owens RC, Nightingale CH, Nicolau DP. Ceftibuten: an overview. Pharmacotherapy 1997; 17: 707-20.
11. Guay DR. Ceftibuten: a new expanded-spectrum oral cephalosporin. Ann Pharmacother 1997; 31: 1022-33.
12. Wiseman LR, Balfour JA. Ceftibuten. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 1994; 47: 784-08.
13. Caron F. Current role of aminoglycosides in the treatment of acute pyelonephritis. Prog Urol 1998; 8: 1077-9.
14. 99m-dimercaptosuccinic acid renal scintigraphy: evolving concepts and future directions. Pediatr Nephrol 1997; 11: 108-20.
15. Benador D, Benador N, Slosman DO, Nussle D, Mermillod B, Girardin E. Cortical scintigraphy in the evaluation of renal parenchymal changes in children with pyelonephritis. J Pediatr 1994; 124: 17-20.
16. Shanon A, Feldman W, Mcdonald P, et al. Evaluation of renal scars by technetium-labeled dimercaptosuccinic acid scan, intravenous urography, and ultrasonography: A comparative study. Pediatrics 1992; 120: 399-03.
17. 99m Technetium-dimercaptosuccinic acid scan for at least five months after infection. Acta Paediatr 1997; 86: 803-7.
18. Stokland E, Hellstrom M, Jakobsson B, Sixt R. Imaging of renal scarring. Acta Paediatr (Suppl) 1999; 431: 13-21.
19. Yen TC, Chen WP, Chang SL, Lui RS, Yeh SH, Lin CY. Technetium-99m-DMSA renal SPECT in diagnosing and monitoring pediatric acute pyelonephritis. J Nucl Med 1996; 37: 1349-53.
20. Hoberman A, Wald ER, Hickey RW, et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatr 1999; 104: 79-86.
21. Jakobsson B, Jacobson SH, Hjalmas K. Vesicoureteric reflux and other risk factors for renal damage: identification of high- and low-risk children. Acta Paedtr (Suppl) 1999; 431: 31-9.
22. Winberg J, Bollgren I, Kallenius G, Svenson SB. Clinical pyelonephritis and focal renal scarring. A selected review of pathogenesis, prevention and prognosis. Pediatr Clin North Am 1982; 29: 801-4.
23. th ed. Maryland : Lippincott Williams & Wilkins, 1999: 835-50.
24. Benador D, Benador N, Slosman DG, Mermillod B, Girardin E. Are younger children at the highest risk of renal sequenlae after pyelonephritis. Lancet 1997; 349: 17-9.
25. 99m-technetium-dimercaptosuccinic acid scintigraphy. J Urol 1992; 147: 1327-32.
26. Jakobsson B, Berg U, Svensson L. Renal scarring after acute pyelonephritis. Arch Dis Child 1994; 70: 111-5.
27. Stokland E, Hellstrom M, Jacobsson B, Jodal U, Sixt R. Renal damage one year after first urinary tract infection:role of dimercaptosuccinic acid scintigraphy. J Pediatr 1996; 129: 815-20.